Conference
1102-P: Identifying Blood Biomarkers for Type 2 Diabetes Subtyping: A Report from the ORIGIN Trial
Abstract
Diabetes (DM) can be classified into 5 subtypes characterized by distinct progression in dysglycaemia and complications. Using 5 clinical variables, we categorized 7017 participants from the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial into 1/auto-immune DM (n=241) , 2/insulin-deficient DM (n=1594) , 3/insulin-resistant DM (n=914) , 4/obesity-related DM (n=1595) , 5/age-related DM (n=2673) .Yet, whether blood …
Authors
PIGEYRE M; GERSTEIN HC; GROOP L; HESS S; PARE G
Volume
71
Publisher
American Diabetes Association
Publication Date
June 1, 2022
DOI
10.2337/db22-1102-p
Conference proceedings
Diabetes
Issue
Supplement_1
ISSN
0012-1797